Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024 8

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024 8

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were

Updated on: February 03,2024 14

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were

Updated on:February 03,2024 14

Study reveals potential target for precision colorectal cancer treatment

by Mallory Locklear,Yale UniversityFlowchart outlining the study. A: Metabolomics data collection and analysis; including targeted analysis of metabolites involved in ferroptosis pathways; B: Id

Updated on: February 18,2024 15

Study reveals potential target for precision colorectal cancer treatment

by Mallory Locklear,Yale UniversityFlowchart outlining the study. A: Metabolomics data collection and analysis; including targeted analysis of metabolites involved in ferroptosis pathways; B: Id

Updated on:February 18,2024 15

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024 15

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024 15

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on: January 23,2024 14

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on:January 23,2024 14

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on: April 01,2024 15

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on:April 01,2024 15

Anti-sedative could alleviate cancer therapy side effects, study suggests

byRockefeller University PressCompared with a control (left), radiation treatment (center) destroys the structure of the mouse small intestine. But a healthy intestinal lining is maintained in t

Updated on: January 16,2024 13

Anti-sedative could alleviate cancer therapy side effects, study suggests

byRockefeller University PressCompared with a control (left), radiation treatment (center) destroys the structure of the mouse small intestine. But a healthy intestinal lining is maintained in t

Updated on:January 16,2024 13

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on: January 11,2024 15

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on:January 11,2024 15

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on: January 13,2024 10

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on:January 13,2024 10

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024 18

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024 18

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa

Updated on: March 27,2024 0

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa

Updated on:March 27,2024 0

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on: January 22,2024 12

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on:January 22,2024 12